echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The results of the fourth batch of national selection, six provinces have clarified the implementation time

    The results of the fourth batch of national selection, six provinces have clarified the implementation time

    • Last Update: 2021-04-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    46 ,6,20,427
     
    6
     
    45,、、、、、。
     
    ,,20,。
     
    ,10。,5,5,。
     
     
    42,《》。
     
    ,2021428,、,。
     
    pharmnet.
    com.
    cn/news/yyzb/" target="_blank">、《》。
     
    ,,3,,。
     
    ,15,30%,。,,30。
     
     
    330,《》,202151。
     
    。,,。
     
      、,3-5,。
     
      ,50%。,。,。
     
      
     
      326,《》,2021430。
     
      416、。、,。
     
      423、、,,。
     
      330,《》,“——”,“”,,,:2021330—2021416。
     
      、、,“”,,。:2021330—2021423。
     
      426,。,430。
     
      3,。
     
      
     
      325,《》,,2021520。
     
     
      420CA,;518,;520。
     
      ,,“”,,。
     
      
     
      319,《》,。
     
     
      According to the notice, all public medical institutions and military medical institutions in Jiangsu Province will start to implement the fourth batch of procurement products announced by the National Procurement and the results of the selection from April 27, 2021.
     
      At the same time, Jiangsu Province requires the fourth batch of nationally-sourced drugs to be purchased in a balanced manner, rational use of drugs, and no group purchases-patients should be guided to use drugs rationally, and selected drugs should be used first, but no single purchase of selected drugs or forced patient change Wait for "one size fits all" measures.
     
      Liaoning
     
      On March 2, the Liaoning Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in Preparations for the Implementation of the Fourth Batch of State-Organized Drug Centralized Procurement (Liaoning) Results".
    From 0:00 on May 1st, Liaoning Province will implement the fourth batch of national Collect the results of the selection in Liaoning.
     
     
      According to the schedule of Liaoning Province:
     
      Before April 20th, the municipal medical insurance bureaus will organize medical institutions to complete the signing of bulk purchase contracts for drug production (business) enterprises.
     
      Before April 20th, the medical insurance agencies of each city shall calculate the prepaid working capital according to the agreed purchase amount of the medical institution (the prepaid working capital shall be allocated to the medical institution in areas where the direct settlement of the medical insurance fund is not implemented).
     
      Before April 30, the relevant selected drugs will be prepared in advance to the relevant medical institutions.
     
      20 provinces and cities issued the fourth batch of national procurement and network notices
     
      According to Cyberlan’s latest review, in addition to the above six provinces, Yunnan, Anhui, Guangdong, Shaanxi, Hunan, Ningxia, Tibet, Sichuan, Heilongjiang, Hainan, Guizhou, Hubei, Shanghai, Gansu, Jiangxi, Tianjin, Jilin, Beijing, Twenty provinces and cities in Qinghai and Inner Mongolia have also issued relevant notices on the results of the fourth batch of national procurement selection results.
     
      Qinghai, Inner Mongolia, Yunnan, and Hunan have notified that the notice is still within the statute of limitations.
    Cyberlan has also compiled them separately.
     
      Qinghai
     
      On April 2, the Qinghai Provincial Drug and Medical Consumables Centralized Purchasing Network issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Drugs Related to the Internet", which clarified that the same category of drugs has passed the consistency evaluation of more than 3 (including 3), no more listing of generic drugs that have not passed the consistency evaluation.
     
      Selected and non-selected drugs that have won the bid (linked to the Internet) in Qinghai Province, and related companies have registered for centralized trading of drugs and medical consumables-"Data reporting in the drug trading system-the fourth batch of national selected drugs price declaration and the fourth batch of national non-selected drugs The price declaration module carries out price declaration separately.
     
      For products that are not listed on the Qinghai Province, relevant companies log on to the Qinghai Province Drug and Medical Consumables Centralized Procurement Network to apply for the fourth batch of nationally organized drugs for centralized procurement of selected drugs and non-selected drugs.
     
      Qinghai also stipulated that selected drugs that did not choose Qinghai Province as the supply area should be directly linked to the Internet at a price no higher than the selected ones; original research drugs and reference preparations (deemed as the same) that were not selected with the same generic name should not be higher than the national minimum purchase price Directly linked to the Internet; unselected drugs with the same generic name through the consistency evaluation, directly linked to the Internet at a price not higher than the selected drugs that selected Qinghai Province as the supply area; the unselected drugs with the same generic name that did not pass the consistency evaluation were lower than the selected Qinghai As a supply area, the province's selected drug prices are not higher than those that have not been selected and passed the consistency evaluation and the lowest purchase price in the country is directly linked to the Internet.
    ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
     
      In 2020, Qinghai Province has selected the same generic name for volume procurement, and if the selected price of the products of different manufacturers is higher than the national selected price, the price will be adjusted according to the non-selected products.
    If the selected price in Qinghai Province’s volume purchase is lower than the national selected price, the Qinghai Province’s selected volume purchase price will still be implemented before the agreed purchase volume is completed during the agreement period.
     
       (1) Corporate information maintenance and price declaration time: April 2, 2021 to April 12, 2021.
     
      (2) Confirmation time of the selected drug distribution relationship: before 18:00 on April 15, 2021.
     
      (3) The application information of non-selected drugs will be publicized and will be posted on the Internet if they meet the requirements, and the time for the selection and confirmation of the distribution relationship will be notified separately.
     
      Inner Mongolia
     
      On March 29, the Inner Mongolia Autonomous Region Medical Procurement Network issued the "Notice on Carrying out the Supplementary Networking of the Fourth Batch of National-Organized Drug Centralized Procurement of Drugs Selected", clarified that the fourth batch of national-organized centralized drug procurement was listed in the selected varieties list in Inner Mongolia.
    The varieties and the drugs that the selected companies intend to sell in the Inner Mongolia Autonomous Region with the same generic name and other specifications of the drug are all within the scope of the listing.
     
      In addition, the fourth batch of countries are encouraged to organize centralized procurement of drugs for selected varieties from other regions to apply for centralized declaration at the selected prices.
     
      Pharmaceutical companies that need to apply for online registration need to go through the following application process: apply for user name and password-fill in qualification information-prepare and submit materials.
     
      The above-mentioned process will be carried out as follows-time to receive user name: April 1st-April 6th, 2021; online information filling time: April 1st-April 7th, 2021.
     
      Yunnan
     
      On March 26, the Yunnan Provincial Drug Centralized Procurement Platform issued the "Notice on the Issues Concerning the Online Transactions of the Fourth Batch of Nationally Organized Drug Centralized Procurement of Drugs Selected" clarified that the results of the fourth batch of nationally organized centralized drug procurement in Yunnan correspond to the list of supply varieties For the drugs with the remarks "sample registration required", the sample registration work will begin immediately.
    Enterprises are required to complete the sample registration according to the prescribed procedures.
     
      After the enterprise completes the sample filing, before 17:00 on April 15, 2021 (except statutory holidays), the Yunnan Provincial Drug Administration will stamp the "Yunnan Province Essential Drugs Bid Sample Recording Form" and the "Statutory Representative Authorization Letter", the original scanned and sent to the e-mail: ynsypjzcgpt@163.
    com, please indicate "project name + company name + basic medicine registration form" in the subject of the e-mail.
     
      The final online transaction time will be notified separately.
     
      Hunan
     
      On March 17, the Hunan Provincial Public Resources Trading Center issued the "Notice on Doing a Good Job in the Preparatory Work Before the Implementation of the Results of the Fourth Batch of National Centralized Procurement of Drugs ", stating that some selected pharmaceutical companies or selected drugs that chose Hunan Province as the supply province The packaging specifications have not been declared on the Hunan Province Procurement Platform, and all relevant companies should do a good job in the declaration of the qualification information of the company or the selected drug in a timely manner.
     
      The selected drug company shall determine the supply packaging of the selected drug before 17:00 on April 1.
    Other packaging quantities and specifications of the drug will be suspended from the Internet, and must be carefully selected and confirmed; then the selected drug distribution company shall be determined, and the fourth batch of nationally selected drugs shall be temporarily selected.
    There is no restriction on the number of distribution entrepreneurs.
     
      It is expected that more provinces will release the implementation time of the fourth batch of national selection results, and Cyberlan will continue to pay attention.
      Medical Network News on April 6th.
    The results of the fourth batch of national procurements have been selected.
    6 provinces have clarified the implementation time, and 20 provinces and municipalities have issued notices to link up the Internet.
    The earliest date is April 27.
     
      6 provinces clarified the implementation time of the fourth batch of national procurement
     
      According to Cyberlan's analysis on April 5, the six provinces of Liaoning, Jiangsu, Ningxia, Henan, Shanxi, and Zhejiang have determined the implementation time of the fourth batch of national procurement.
     
      In addition, according to the statistics of Cyberlan, 20 provinces and cities have issued documents requesting the fourth batch of nationally selected varieties to be declared online.
    I believe they will also gradually clarify the final landing time.
     
      Up to now, only less than 10 provinces and cities have not issued notices on the results of the fourth batch of national procurement selection results.
    According to official sources, the fourth batch of centralized procurement of medicines is expected to land around May.
    It is believed that as May approaches, more regions will issue relevant online notifications of the fourth batch of national selection results or directly clarify the execution time of the results.
     
      Zhejiang
     
      On April 2, the Zhejiang Medical Insurance Bureau issued the "Announcement on the Implementation of the Results of the Fourth Batch of National Organizations for Centralized Procurement of Drugs" officially announced the implementation time of the fourth batch of national procurement results.
     
      According to the announcement, the fourth batch of national procurement will be implemented in Zhejiang on April 28, 2021.
    The scope of implementation is all public medical institutions, military medical institutions, and voluntary medical insurance designated social medical institutions and medical insurance designated retail stores in Zhejiang.
    Pharmacy .
     
      As for the pharmnet.
    com.
    cn/news/yyzb/" target="_blank">procurement and use of selected drugs , the prepayment of funds and other policies are still implemented in accordance with the "Zhejiang Province Implementation Plan for the Implementation of the State-Organized Drug Centralized Procurement and Use of Pilot Projects to Expand the Regional Scope".
     
      According to Cyberlane’s understanding, the above implementation plan stipulates that if there are more than 3 manufacturers that have passed the quality and efficacy consistency evaluation of the same type of drug as the selected drug, the online transaction of the drug that has not passed the consistency evaluation will be suspended under the condition of ensuring the supply.
    qualifications.
     
      In addition, medical insurance agencies at all levels, within 15 working days of signing the purchase and sales agreement, prepay 30% of the agreed purchase amount for the year to the medical institution as a working capital for the payment of drug purchases by the medical institution to the enterprise.
    As the first person responsible for the settlement of medicines, medical institutions shall settle settlements with the enterprise in a timely manner in accordance with the provisions of the agreement, and it shall not exceed 30 days from the acceptance of the goods to the payment.
     
      Shanxi
     
      On March 30, the Shanxi Medical Insurance Bureau issued the "Notice on Fully Implementing the Fourth Batch of National Organizations for the Centralized Procurement and Use of Drugs", stating that all medical institutions in Shanxi Province participating in this centralized procurement will implement the implementation on May 1, 2021.
    The results of the fourth batch of national joint procurement office cloths.
     
      All medical institutions in the province participating in this centralized procurement must purchase and use selected drugs in accordance with regulations through the provincial centralized procurement platform for pharmaceutical equipment.
    The purchase agreement is signed every year during the purchase cycle.
    When the purchase agreement is renewed, the agreed purchase amount shall in principle be no less than the agreed purchase amount of the selected drug in the previous year.
     
      The selected drugs are independently commissioned by the selected companies to distribute them by reputable distribution companies with distribution capabilities or on their own.
    In principle, 3-5 distribution companies are selected in each coordinating area, and the distribution must cover all medical institutions participating in mass procurement.
     
      On the basis of the total budget, the medical insurance agencies in the overall planning area will prepay 50% of the annual agreed purchase amount of the medical institution to the medical institution.
    The advance payment of the medical insurance fund shall be collected and turned over to the special financial account by the medical insurance handling agencies of each coordinating district within two months after the end of a procurement cycle.
    The medical institution shall settle the payment with the enterprise in a timely manner as agreed in the purchase contract, and the settlement time shall not exceed the end of the next month after the delivery is qualified.
     
      Henan
     
      On March 26, the Henan Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of National Organizations for the Implementation of Centralized Procurement of Drugs".
    It is clear that the fourth batch of national centralized procurement will be implemented before April 30, 2021.
    The result of the selection of the product specification.
     
      Prior to April 16th, the selected companies will do a good job in maintaining the qualifications of the selected companies and maintaining the information of the selected products.
    At the same time, we will select an operating company with distribution capability and good reputation to distribute the selected drugs, and establish a distribution relationship.
     
      Before April 23, medical institutions, selected enterprises , and operating companies log on to the provincial pharmaceutical procurement platform and confirm the three-party purchase and sale contract before the pharmaceutical institution can proceed with platform procurement.
     
      On March 30, the Henan Provincial Public Resources Transaction Service Center issued the "Notice on Doing a Good Job in the Fourth Batch of National Organizations for Centralized Procurement of Selected Drugs Online Maintenance and Distribution Relations and Signing of Purchase and Sales Contracts.
    " "Pharmaceutical Procurement System—Trading Platform—Pharmaceutical Transaction System", click the "Maintain Distribution Relationship" module to independently determine the distribution company, establish an online distribution relationship, and maintain the distribution relationship.
    Time: March 30, 2021-April 16, 2021.
     
      Medical institutions, selected companies, and distribution companies log in to the drug transaction system and click on the "National Organization and Quantity Purchase Product Contract Management" module to view and confirm the content of the contract, and sign a tripartite electronic transaction contract.
    Time for signing the purchase and sale contract: March 30, 2021-April 23, 2021.
     
      Starting from April 26, the Henan Provincial Public Resource Trading Center will uniformly adjust the prices of related drugs.
    Medical insurance departments at all levels supervise and urge medical institutions within their jurisdiction to purchase the selected drugs in a timely manner at the selected price to ensure that patients in Henan Province can purchase the selected drugs at the selected price on April 30.
     
      If there are 3 or more manufacturing companies that have passed the consistency evaluation of the selected drugs sold on the Internet in Henan Province with the generic name drugs, the drugs that have not passed the consistency evaluation will no longer be listed on the Internet.
     
      Ningxia
     
      On March 25, the Ningxia Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of National Organized Drug Centralized Procurement", which clarified that according to the results and work requirements of the fourth batch of nationally organized drug centralized procurement, it is scheduled for May 2021 Implementation on the 20th.
     
     
      Before April 20, complete the CA certificate application and log in to the Ningxia Pharmaceutical Procurement Platform to sign the purchase and sales contract; before May 18, complete the signing of the purchase and sales agreement; and officially implement the fourth batch of national organization drug procurement results in Ningxia on May 20.
     
      At the same time, Ningxia proposed that all purchasing units should formulate a reasonable procurement plan, and no “one size fits all” behaviors such as single procurement of selected drugs or forced patient changes to ensure rational use of drugs and promote orderly supply and demand.
     
      Jiangsu
     
      On March 19, the Jiangsu Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of State-Organized Drug Centralized Procurement Results", which officially determined the launch time of the fourth batch of nationally selected results in Jiangsu Province.
     
     
      According to the notice, all public medical institutions and military medical institutions in Jiangsu Province will start to implement the fourth batch of procurement products announced by the National Procurement and the results of the selection from April 27, 2021.
     
      At the same time, Jiangsu Province requires the fourth batch of nationally-sourced drugs to be purchased in a balanced manner, rational use of drugs, and no group purchases-patients should be guided to use drugs rationally, and selected drugs should be used first, but no single purchase of selected drugs or forced patient change Wait for "one size fits all" measures.
     
      Liaoning
     
      On March 2, the Liaoning Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in Preparations for the Implementation of the Fourth Batch of State-Organized Drug Centralized Procurement (Liaoning) Results".
    From 0:00 on May 1st, Liaoning Province will implement the fourth batch of national Collect the results of the selection in Liaoning.
     
     
      According to the schedule of Liaoning Province:
     
      Before April 20th, the municipal medical insurance bureaus will organize medical institutions to complete the signing of bulk purchase contracts for drug production (business) enterprises.
     
      Before April 20th, the medical insurance agencies of each city shall calculate the prepaid working capital according to the agreed purchase amount of the medical institution (the prepaid working capital shall be allocated to the medical institution in areas where the direct settlement of the medical insurance fund is not implemented).
     
      Before April 30, the relevant selected drugs will be prepared in advance to the relevant medical institutions.
     
      20 provinces and cities issued the fourth batch of national procurement and network notices
     
      According to Cyberlan’s latest review, in addition to the above six provinces, Yunnan, Anhui, Guangdong, Shaanxi, Hunan, Ningxia, Tibet, Sichuan, Heilongjiang, Hainan, Guizhou, Hubei, Shanghai, Gansu, Jiangxi, Tianjin, Jilin, Beijing, Twenty provinces and cities in Qinghai and Inner Mongolia have also issued relevant notices on the results of the fourth batch of national procurement selection results.
     
      Qinghai, Inner Mongolia, Yunnan, and Hunan have notified that the notice is still within the statute of limitations.
    Cyberlan has also compiled them separately.
     
      Qinghai
     
      On April 2, the Qinghai Provincial Drug and Medical Consumables Centralized Purchasing Network issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Drugs Related to the Internet", which clarified that the same category of drugs has passed the consistency evaluation of more than 3 (including 3), no more listing of generic drugs that have not passed the consistency evaluation.
     
      Selected and non-selected drugs that have won the bid (linked to the Internet) in Qinghai Province, and related companies have registered for centralized trading of drugs and medical consumables-"Data reporting in the drug trading system-the fourth batch of national selected drugs price declaration and the fourth batch of national non-selected drugs The price declaration module carries out price declaration separately.
     
      For products that are not listed on the Qinghai Province, relevant companies log on to the Qinghai Province Drug and Medical Consumables Centralized Procurement Network to apply for the fourth batch of nationally organized drugs for centralized procurement of selected drugs and non-selected drugs.
     
      Qinghai also stipulated that selected drugs that did not choose Qinghai Province as the supply area should be directly linked to the Internet at a price no higher than the selected ones; original research drugs and reference preparations (deemed as the same) that were not selected with the same generic name should not be higher than the national minimum purchase price Directly linked to the Internet; unselected drugs with the same generic name through the consistency evaluation, directly linked to the Internet at a price not higher than the selected drugs that selected Qinghai Province as the supply area; the unselected drugs with the same generic name that did not pass the consistency evaluation were lower than the selected Qinghai As a supply area, the province's selected drug prices are not higher than those that have not been selected and passed the consistency evaluation and the lowest purchase price in the country is directly linked to the Internet.
    ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
     
      In 2020, Qinghai Province has selected the same generic name for volume procurement, and if the selected price of the products of different manufacturers is higher than the national selected price, the price will be adjusted according to the non-selected products.
    If the selected price in Qinghai Province’s volume purchase is lower than the national selected price, the Qinghai Province’s selected volume purchase price will still be implemented before the agreed purchase volume is completed during the agreement period.
     
       (1) Corporate information maintenance and price declaration time: April 2, 2021 to April 12, 2021.
     
      (2) Confirmation time of the selected drug distribution relationship: before 18:00 on April 15, 2021.
     
      (3) The application information of non-selected drugs will be publicized and will be posted on the Internet if they meet the requirements, and the time for the selection and confirmation of the distribution relationship will be notified separately.
     
      Inner Mongolia
     
      On March 29, the Inner Mongolia Autonomous Region Medical Procurement Network issued the "Notice on Carrying out the Supplementary Networking of the Fourth Batch of National-Organized Drug Centralized Procurement of Drugs Selected", clarified that the fourth batch of national-organized centralized drug procurement was listed in the selected varieties list in Inner Mongolia.
    The varieties and the drugs that the selected companies intend to sell in the Inner Mongolia Autonomous Region with the same generic name and other specifications of the drug are all within the scope of the listing.
     
      In addition, the fourth batch of countries are encouraged to organize centralized procurement of drugs for selected varieties from other regions to apply for centralized declaration at the selected prices.
     
      Pharmaceutical companies that need to apply for online registration need to go through the following application process: apply for user name and password-fill in qualification information-prepare and submit materials.
     
      The above-mentioned process will be carried out as follows-time to receive user name: April 1st-April 6th, 2021; online information filling time: April 1st-April 7th, 2021.
     
      Yunnan
     
      On March 26, the Yunnan Provincial Drug Centralized Procurement Platform issued the "Notice on the Issues Concerning the Online Transactions of the Fourth Batch of Nationally Organized Drug Centralized Procurement of Drugs Selected" clarified that the results of the fourth batch of nationally organized centralized drug procurement in Yunnan correspond to the list of supply varieties For the drugs with the remarks "sample registration required", the sample registration work will begin immediately.
    Enterprises are required to complete the sample registration according to the prescribed procedures.
     
      After the enterprise completes the sample filing, before 17:00 on April 15, 2021 (except statutory holidays), the Yunnan Provincial Drug Administration will stamp the "Yunnan Province Essential Drugs Bid Sample Recording Form" and the "Statutory Representative Authorization Letter", the original scanned and sent to the e-mail: ynsypjzcgpt@163.
    com, please indicate "project name + company name + basic medicine registration form" in the subject of the e-mail.
     
      The final online transaction time will be notified separately.
     
      Hunan
     
      On March 17, the Hunan Provincial Public Resources Trading Center issued the "Notice on Doing a Good Job in the Preparatory Work Before the Implementation of the Results of the Fourth Batch of National Centralized Procurement of Drugs ", stating that some selected pharmaceutical companies or selected drugs that chose Hunan Province as the supply province The packaging specifications have not been declared on the Hunan Province Procurement Platform, and all relevant companies should do a good job in the declaration of the qualification information of the company or the selected drug in a timely manner.
     
      The selected drug company shall determine the supply packaging of the selected drug before 17:00 on April 1.
    Other packaging quantities and specifications of the drug will be suspended from the Internet, and must be carefully selected and confirmed; then the selected drug distribution company shall be determined, and the fourth batch of nationally selected drugs shall be temporarily selected.
    There is no restriction on the number of distribution entrepreneurs.
     
      It is expected that more provinces will release the implementation time of the fourth batch of national selection results, and Cyberlan will continue to pay attention.
      Medical Network News on April 6th.
    The results of the fourth batch of national procurements have been selected.
    6 provinces have clarified the implementation time, and 20 provinces and municipalities have issued notices to link up the Internet.
    The earliest date is April 27.
     
      6 provinces clarified the implementation time of the fourth batch of national procurement
      6 provinces clarified the implementation time of the fourth batch of national procurement
     
      According to Cyberlan's analysis on April 5, the six provinces of Liaoning, Jiangsu, Ningxia, Henan, Shanxi, and Zhejiang have determined the implementation time of the fourth batch of national procurement.
     
      In addition, according to the statistics of Cyberlan, 20 provinces and cities have issued documents requesting the fourth batch of nationally selected varieties to be declared online.
    I believe they will also gradually clarify the final landing time.
     
      Up to now, only less than 10 provinces and cities have not issued notices on the results of the fourth batch of national procurement selection results.
    According to official sources, the fourth batch of centralized procurement of medicines is expected to land around May.
    It is believed that as May approaches, more regions will issue relevant online notifications of the fourth batch of national selection results or directly clarify the execution time of the results.
     
      Zhejiang
      Zhejiang
     
      On April 2, the Zhejiang Medical Insurance Bureau issued the "Announcement on the Implementation of the Results of the Fourth Batch of National Organizations for Centralized Procurement of Drugs" officially announced the implementation time of the fourth batch of national procurement results.
     
      According to the announcement, the fourth batch of national procurement will be implemented in Zhejiang on April 28, 2021.
    The scope of implementation is all public medical institutions, military medical institutions, and voluntary medical insurance designated social medical institutions and medical insurance designated retail stores in Zhejiang.
    Pharmacy .
    Pharmacy pharmacy pharmacy
     
      As for the pharmnet.
    com.
    cn/news/yyzb/" target="_blank">procurement and use of selected drugs , the prepayment of funds and other policies are still implemented in accordance with the "Zhejiang Province Implementation Plan for the Implementation of the State-Organized Drug Centralized Procurement and Use of Pilot Projects to Expand the Regional Scope".
    pharmnet.
    com.
    cn/news/yyzb/" target="_blank">Procurementpharmnet.
    com.
    cn/news/yyzb/" target="_blank"> Procurement Procurement
     
      According to Cyberlane’s understanding, the above implementation plan stipulates that if there are more than 3 manufacturers that have passed the quality and efficacy consistency evaluation of the same type of drug as the selected drug, the online transaction of the drug that has not passed the consistency evaluation will be suspended under the condition of ensuring the supply.
    qualifications.
     
      In addition, medical insurance agencies at all levels, within 15 working days of signing the purchase and sales agreement, prepay 30% of the agreed purchase amount for the year to the medical institution as a working capital for the payment of drug purchases by the medical institution to the enterprise.
    As the first person responsible for the settlement of medicines, medical institutions shall settle settlements with the enterprise in a timely manner in accordance with the provisions of the agreement, and it shall not exceed 30 days from the acceptance of the goods to the payment.
     
      Shanxi
      Shanxi
     
      On March 30, the Shanxi Medical Insurance Bureau issued the "Notice on Fully Implementing the Fourth Batch of National Organizations for the Centralized Procurement and Use of Drugs", stating that all medical institutions in Shanxi Province participating in this centralized procurement will implement the implementation on May 1, 2021.
    The results of the fourth batch of national joint procurement office cloths.
     
      All medical institutions in the province participating in this centralized procurement must purchase and use selected drugs in accordance with regulations through the provincial centralized procurement platform for pharmaceutical equipment.
    The purchase agreement is signed every year during the purchase cycle.
    When the purchase agreement is renewed, the agreed purchase amount shall in principle be no less than the agreed purchase amount of the selected drug in the previous year.
     
      The selected drugs are independently commissioned by the selected companies to distribute them by reputable distribution companies with distribution capabilities or on their own.
    In principle, 3-5 distribution companies are selected in each coordinating area, and the distribution must cover all medical institutions participating in mass procurement.
     
      On the basis of the total budget, the medical insurance agencies in the overall planning area will prepay 50% of the annual agreed purchase amount of the medical institution to the medical institution.
    The advance payment of the medical insurance fund shall be collected and turned over to the special financial account by the medical insurance handling agencies of each coordinating district within two months after the end of a procurement cycle.
    The medical institution shall settle the payment with the enterprise in a timely manner as agreed in the purchase contract, and the settlement time shall not exceed the end of the next month after the delivery is qualified.
     
      Henan
      Henan
     
      On March 26, the Henan Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of National Organizations for the Implementation of Centralized Procurement of Drugs".
    It is clear that the fourth batch of national centralized procurement will be implemented before April 30, 2021.
    The result of the selection of the product specification.
     
      Prior to April 16th, the selected companies will do a good job in maintaining the qualifications of the selected companies and maintaining the information of the selected products.
    At the same time, we will select an operating company with distribution capability and good reputation to distribute the selected drugs, and establish a distribution relationship.
     
      Before April 23, medical institutions, selected enterprises , and operating companies log on to the provincial pharmaceutical procurement platform and confirm the three-party purchase and sale contract before the pharmaceutical institution can proceed with platform procurement.
    Pharmaceutical Pharmaceutical Pharmaceutical Enterprise Enterprise Enterprise
     
      On March 30, the Henan Provincial Public Resources Transaction Service Center issued the "Notice on Doing a Good Job in the Fourth Batch of National Organizations for Centralized Procurement of Selected Drugs Online Maintenance and Distribution Relations and Signing of Purchase and Sales Contracts.
    " "Pharmaceutical Procurement System—Trading Platform—Pharmaceutical Transaction System", click the "Maintain Distribution Relationship" module to independently determine the distribution company, establish an online distribution relationship, and maintain the distribution relationship.
    Time: March 30, 2021-April 16, 2021.
     
      Medical institutions, selected companies, and distribution companies log in to the drug transaction system and click on the "National Organization and Quantity Purchase Product Contract Management" module to view and confirm the content of the contract, and sign a tripartite electronic transaction contract.
    Time for signing the purchase and sale contract: March 30, 2021-April 23, 2021.
     
      Starting from April 26, the Henan Provincial Public Resource Trading Center will uniformly adjust the prices of related drugs.
    Medical insurance departments at all levels supervise and urge medical institutions within their jurisdiction to purchase the selected drugs in a timely manner at the selected price to ensure that patients in Henan Province can purchase the selected drugs at the selected price on April 30.
     
      If there are 3 or more manufacturing companies that have passed the consistency evaluation of the selected drugs sold on the Internet in Henan Province with the generic name drugs, the drugs that have not passed the consistency evaluation will no longer be listed on the Internet.
     
      Ningxia
      Ningxia
     
      On March 25, the Ningxia Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of National Organized Drug Centralized Procurement", which clarified that according to the results and work requirements of the fourth batch of nationally organized drug centralized procurement, it is scheduled for May 2021 Implementation on the 20th.
     
     
      Before April 20, complete the CA certificate application and log in to the Ningxia Pharmaceutical Procurement Platform to sign the purchase and sales contract; before May 18, complete the signing of the purchase and sales agreement; and officially implement the fourth batch of national organization drug procurement results in Ningxia on May 20.
     
      At the same time, Ningxia proposed that all purchasing units should formulate a reasonable procurement plan, and no “one size fits all” behaviors such as single procurement of selected drugs or forced patient changes to ensure rational use of drugs and promote orderly supply and demand.
     
      Jiangsu
      Jiangsu
     
      On March 19, the Jiangsu Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fourth Batch of State-Organized Drug Centralized Procurement Results", which officially determined the launch time of the fourth batch of nationally selected results in Jiangsu Province.
     
     
      According to the notice, all public medical institutions and military medical institutions in Jiangsu Province will start to implement the fourth batch of procurement products announced by the National Procurement and the results of the selection from April 27, 2021.
     
      At the same time, Jiangsu Province requires the fourth batch of nationally-sourced drugs to be purchased in a balanced manner, rational use of drugs, and no group purchases-patients should be guided to use drugs rationally, and selected drugs should be used first, but no single purchase of selected drugs or forced patient change Wait for "one size fits all" measures.
     
      Liaoning
      Liaoning
     
      On March 2, the Liaoning Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in Preparations for the Implementation of the Fourth Batch of State-Organized Drug Centralized Procurement (Liaoning) Results".
    From 0:00 on May 1st, Liaoning Province will implement the fourth batch of national Collect the results of the selection in Liaoning.
     
     
      According to the schedule of Liaoning Province:
      According to the schedule of Liaoning Province:
     
      Before April 20th, the municipal medical insurance bureaus will organize medical institutions to complete the signing of bulk purchase contracts for drug production (business) enterprises.
     
      Before April 20th, the medical insurance agencies of each city shall calculate the prepaid working capital according to the agreed purchase amount of the medical institution (the prepaid working capital shall be allocated to the medical institution in areas where the direct settlement of the medical insurance fund is not implemented).
     
      Before April 30, the relevant selected drugs will be prepared in advance to the relevant medical institutions.
     
      20 provinces and cities issued the fourth batch of national procurement and network notices
      20 provinces and cities issued the fourth batch of national procurement and network notices
     
      According to Cyberlan’s latest review, in addition to the above six provinces, Yunnan, Anhui, Guangdong, Shaanxi, Hunan, Ningxia, Tibet, Sichuan, Heilongjiang, Hainan, Guizhou, Hubei, Shanghai, Gansu, Jiangxi, Tianjin, Jilin, Beijing, Twenty provinces and cities in Qinghai and Inner Mongolia have also issued relevant notices on the results of the fourth batch of national procurement selection results.
     
      Qinghai, Inner Mongolia, Yunnan, and Hunan have notified that the notice is still within the statute of limitations.
    Cyberlan has also compiled them separately.
     
      Qinghai
      Qinghai
     
      On April 2, the Qinghai Provincial Drug and Medical Consumables Centralized Purchasing Network issued the "Notice on Carrying out the Fourth Batch of National-Organized Drug Centralized Procurement of Drugs Related to the Internet", which clarified that the same category of drugs has passed the consistency evaluation of more than 3 (including 3), no more listing of generic drugs that have not passed the consistency evaluation.
     
      Selected and non-selected drugs that have won the bid (linked to the Internet) in Qinghai Province, and related companies have registered for centralized trading of drugs and medical consumables-"Data reporting in the drug trading system-the fourth batch of national selected drugs price declaration and the fourth batch of national non-selected drugs The price declaration module carries out price declaration separately.
     
      For products that are not listed on the Qinghai Province, relevant companies log on to the Qinghai Province Drug and Medical Consumables Centralized Procurement Network to apply for the fourth batch of nationally organized drugs for centralized procurement of selected drugs and non-selected drugs.
     
      Qinghai also stipulated that selected drugs that did not choose Qinghai Province as the supply area should be directly linked to the Internet at a price no higher than the selected ones; original research drugs and reference preparations (deemed as the same) that were not selected with the same generic name should not be higher than the national minimum purchase price Directly linked to the Internet; unselected drugs with the same generic name through the consistency evaluation, directly linked to the Internet at a price not higher than the selected drugs that selected Qinghai Province as the supply area; the unselected drugs with the same generic name that did not pass the consistency evaluation were lower than the selected Qinghai As a supply area, the province's selected drug prices are not higher than those that have not been selected and passed the consistency evaluation and the lowest purchase price in the country is directly linked to the Internet.
    ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
     
      In 2020, Qinghai Province has selected the same generic name for volume procurement, and if the selected price of the products of different manufacturers is higher than the national selected price, the price will be adjusted according to the non-selected products.
    If the selected price in Qinghai Province’s volume purchase is lower than the national selected price, the Qinghai Province’s selected volume purchase price will still be implemented before the agreed purchase volume is completed during the agreement period.
     
       (1) Corporate information maintenance and price declaration time: April 2, 2021 to April 12, 2021.
     
      (2) Confirmation time of the selected drug distribution relationship: before 18:00 on April 15, 2021.
     
      (3) The application information of non-selected drugs will be publicized and will be posted on the Internet if they meet the requirements, and the time for the selection and confirmation of the distribution relationship will be notified separately.
     
      Inner Mongolia
      Inner Mongolia
     
      On March 29, the Inner Mongolia Autonomous Region Medical Procurement Network issued the "Notice on Carrying out the Supplementary Networking of the Fourth Batch of National-Organized Drug Centralized Procurement of Drugs Selected", clarified that the fourth batch of national-organized centralized drug procurement was listed in the selected varieties list in Inner Mongolia.
    The varieties and the drugs that the selected companies intend to sell in the Inner Mongolia Autonomous Region with the same generic name and other specifications of the drug are all within the scope of the listing.
     
      In addition, the fourth batch of countries are encouraged to organize centralized procurement of drugs for selected varieties from other regions to apply for centralized declaration at the selected prices.
     
      Pharmaceutical companies that need to apply for online registration need to go through the following application process: apply for user name and password-fill in qualification information-prepare and submit materials.
     
      The above-mentioned process will be carried out as follows-time to receive user name: April 1st-April 6th, 2021; online information filling time: April 1st-April 7th, 2021.
     
      Yunnan
      Yunnan
     
      On March 26, the Yunnan Provincial Drug Centralized Procurement Platform issued the "Notice on the Issues Concerning the Online Transactions of the Fourth Batch of Nationally Organized Drug Centralized Procurement of Drugs Selected" clarified that the results of the fourth batch of nationally organized centralized drug procurement in Yunnan correspond to the list of supply varieties For the drugs with the remarks "sample registration required", the sample registration work will begin immediately.
    Enterprises are required to complete the sample registration according to the prescribed procedures.
     
      After the enterprise completes the sample filing, before 17:00 on April 15, 2021 (except statutory holidays), the Yunnan Provincial Drug Administration will stamp the "Yunnan Province Essential Drugs Bid Sample Recording Form" and the "Statutory Representative Authorization Letter", the original scanned and sent to the e-mail: ynsypjzcgpt@163.
    com, please indicate "project name + company name + basic medicine registration form" in the subject of the e-mail.
     
      The final online transaction time will be notified separately.
     
      Hunan
      Hunan
     
      On March 17, the Hunan Provincial Public Resources Trading Center issued the "Notice on Doing a Good Job in the Preparatory Work Before the Implementation of the Results of the Fourth Batch of National Centralized Procurement of Drugs ", stating that some selected pharmaceutical companies or selected drugs that chose Hunan Province as the supply province The packaging specifications have not been declared on the Hunan Province Procurement Platform, and all relevant companies should do a good job in the declaration of the qualification information of the company or the selected drug in a timely manner.
    Medicine, medicine, medicine
     
      The selected drug company shall determine the supply packaging of the selected drug before 17:00 on April 1.
    Other packaging quantities and specifications of the drug will be suspended from the Internet, and must be carefully selected and confirmed; then the selected drug distribution company shall be determined, and the fourth batch of nationally selected drugs shall be temporarily selected.
    There is no restriction on the number of distribution entrepreneurs.
     
      It is expected that more provinces will release the implementation time of the fourth batch of national selection results, and Cyberlan will continue to pay attention.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.